Seems the SecDef just implemented a new directive mandating screening for low testosterone for all Service Members over 30yrs old. A conversation about this seems timely given the recent episodes about testosterone and Signal.
Seems to me this will ultimately lead to poor testing, over treatment, possibly bad outcomes as well as driving up healthcare costs (for the enterprise, obviously not for the soldier, but DHA has funding issues already).
How can clinicians who may be directed to carry this out best ensure they are doing the best for their patients? Being forced to practice medicine in a manner not supported by best practices is a bit concerning.